Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SOFINNOVA BIOVELOCITA II UP : revenue, balance sheet and financial ratios

SOFINNOVA BIOVELOCITA II UP is a French company founded 2 years ago, specialized in the sector Gestion de fonds. Based in PARIS (75009), this company of category PME shows in 2024 a net income positive of 406€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOFINNOVA BIOVELOCITA II UP (SIREN 979861523)
Indicator 2024
Revenue N/C
Net income 406 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, SOFINNOVA BIOVELOCITA II UP generates positive net income of 406 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

406 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

0.0%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
SOFINNOVA BIOVELOCITA II UP

Sector positioning

Debt ratio
0.0 2024
2024
Q1: 0.0
Med: 8.29
Q3: 92.98
Excellent

In 2024, the debt ratio of SOFINNOVA BIOVELOCITA II UP (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
0.0% 2024
2024
Q1: 4.66%
Med: 48.47%
Q3: 87.35%
Average

In 2024, the financial autonomy of SOFINNOVA BIOVELOCITA II UP (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2024
2024
Q1: -0.01 years
Med: 0.0 years
Q3: 3.01 years
Good

In 2024, the repayment capacity of SOFINNOVA BIOVELOCITA II UP (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Positioning of SOFINNOVA BIOVELOCITA II UP in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 62 transactions of similar company sales in 2024, the value of SOFINNOVA BIOVELOCITA II UP is estimated at 3 000 € (range 852€ - 5 945€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
62 tx
0k€ 3k€ 5k€
3 000 € Range: 852€ - 5 945€
NAF 5 année 2024

Valuation method used

Net Income Multiple
406 € × 7.4x = 3 001 €
Range: 852€ - 5 945€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare SOFINNOVA BIOVELOCITA II UP with other companies in the same sector:

Frequently asked questions about SOFINNOVA BIOVELOCITA II UP

What is the revenue of SOFINNOVA BIOVELOCITA II UP ?

The revenue of SOFINNOVA BIOVELOCITA II UP is not publicly disclosed (confidential accounts filed with INPI).

Is SOFINNOVA BIOVELOCITA II UP profitable?

Yes, SOFINNOVA BIOVELOCITA II UP generated a net profit of 406€ in 2024.

Where is the headquarters of SOFINNOVA BIOVELOCITA II UP ?

The headquarters of SOFINNOVA BIOVELOCITA II UP is located in PARIS (75009), in the department Paris.

Where to find the tax return of SOFINNOVA BIOVELOCITA II UP ?

The tax return of SOFINNOVA BIOVELOCITA II UP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOFINNOVA BIOVELOCITA II UP operate?

SOFINNOVA BIOVELOCITA II UP operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.